F10
Anti-F10 Recombinant Antibody Products
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC-P
Compare
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, IHC
Compare
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB
Compare
-
- Species Reactivity: Human
- Type: Mouse antibody
- Application: WB
Compare
-
- Species Reactivity: Bovine
- Type: Mouse antibody
- Application: RIA, WB, ELISA
Compare
-
- Species Reactivity: Human
Compare
-
- Species Reactivity: Bovine, Canine, Human, Sheep, Porcine, Rabbit
- Type: Mouse IgG1
- Application: Inhib, RIA, WB
Compare
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, Inhib, WB
Compare
-
- Species Reactivity: Human
- Type: ADCC enhanced antibody
Compare
-
- Species Reactivity: Human
- Type: Antibody
Compare
-
- Scaffold Name: Ecotin
- Target: Fxa
- Species Reactivity: Human
- Derivation: Phage display
Compare
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides.